Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) was the target of a large growth in short interest during the month of May. As of May 29th, there was short interest totaling 258,098 shares, a growth of 244.1% from the May 14th total of 75,000 shares. Based on an average daily volume of 227 shares, the days-to-cover ratio is currently 1,137.0 days.
Viva Biotech Price Performance
Shares of Viva Biotech stock opened at $0.15 on Thursday. The business has a fifty day simple moving average of $0.27 and a two-hundred day simple moving average of $0.28. Viva Biotech has a 1 year low of $0.15 and a 1 year high of $0.20.
About Viva Biotech
Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.
With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.
Read More
- Five stocks we like better than Viva Biotech
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
